Bethesda, Md., July 26, 2016 – The Parenteral Drug Association (PDA) proudly announces the appearance of more than 25 U.S. FDA officials as speakers and moderators for the Silver, 25th Anniversary PDA/FDA Joint Regulatory Conference at the Renaissance Washington, DC Downtown Hotel, September 12-14, 2016.
The 2016 PDA/FDA Joint Regulatory Conference will be "celebrating 25 years of addressing global regulatory strategy" with a mix of presentations by U.S. FDA officials and the corresponding industry perspectives by high-level pharmaceutical and biopharmaceutical leaders. The following FDA centers and offices will be represented:
- Office of the Commissioner
- Center for Drug Evaluation and Research
- Center for Biologics Evaluation and Research
- Center for Veterinary Medicine
- Center for Devices and Radiological Health
- Office of Regulatory Affairs
"For 100 years, U.S. FDA regulations have been a central consideration in manufacturing pharmaceutical products for the U.S. market, and around the world. Over the last 25 years, the PDA/FDA Joint Regulatory Conference has grown into the key forum for manufacturers around the world to learn how to navigate these requirements," said PDA President Richard Johnson.
The 2016 conference is themed, "Aligning Manufacturing Goals with Patient needs through Successful Innovation and Compliance." The two-and-a-half day meeting features several plenary sessions, break-out sessions, breakfast sessions and special PDA Interest Group sessions.
Interested members of the press can request a press pass.